ThermoGenesis Holdings to Announce Financial Results for the Second Quarter Ended June 30, 2021 and Provide a Corporate Strategic Update

Rhea-AI Summary

ThermoGenesis Holdings, Inc. (Nasdaq: THMO) will release its financial results for Q2 2021 on August 12, 2021, after market close. A corporate strategic update will accompany the financial results, followed by a conference call at 1:30 p.m. PT/4:30 p.m. ET. Investors can participate by calling specified numbers or accessing a live webcast. ThermoGenesis specializes in automated technologies for CAR-T and cell-based therapies, including the CAR-TXpress™ platform. More details are available on their website.

RANCHO CORDOVA, Calif., Aug. 5, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the second quarter ended June 30, 2021 and provide a corporate strategic update on Thursday, August 12, 2021, after the close of trading. A conference call and webcast will follow at 1:30 p.m. PT/ 4:30 p.m. ET.

To participate in the conference call, please dial 1-844-889-4331 (domestic), 1-412-380-7406 (international) or 1-866-605-3852 (Canada). To access a live webcast of the call, please visit: https://thermogenesis.com/investors/news-and-events/events-webcasts.

A webcast replay will be available on ThermoGenesis' website for three months by visiting the Investor page of the Company's website at www.thermogenesis.com.

About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. For more information about ThermoGenesis, please visit: www.thermogenesis.com.

Company Contact:
Wendy Samford
916-858-5191
ir@ThermoGenesis.com

Investor Contact:
Paula Schwartz, Rx Communications
917-322-2216
pschwartz@rxir.com

View original content:https://www.prnewswire.com/news-releases/thermogenesis-holdings-to-announce-financial-results-for-the-second-quarter-ended-june-30-2021-and-provide-a-corporate-strategic-update-301349669.html

SOURCE ThermoGenesis Holdings, Inc.

FAQ

When will ThermoGenesis announce its Q2 2021 financial results?

ThermoGenesis will announce its Q2 2021 financial results on August 12, 2021, after the close of trading.

What time is the ThermoGenesis conference call scheduled?

The ThermoGenesis conference call is scheduled for 1:30 p.m. PT/4:30 p.m. ET on August 12, 2021.

How can I access the ThermoGenesis Q2 2021 financial results webcast?

You can access the webcast for the ThermoGenesis Q2 2021 financial results by visiting their investors' page on their official website.

What does ThermoGenesis specialize in?

ThermoGenesis specializes in automated technologies for CAR-T and other cell-based therapies.